Tigecycline for severe Clostridium difficile infection
Ashley Thomas, Farhan Anwar Khan, Nizam Uddin, Mark R. Wallace
Abstract
Ashley Thomas, Farhan Anwar Khan, Nizam Uddin, Mark R. Wallace
Abstract
Limited data suggest that tigecycline may be of value in the treatment of Clostridiumdifficile infection. We reviewed our experience using tigecycline to treat severe c. difficile and compared outcomes to similarly ill patients who did not receive tigecycline. We found no difference between the groups. Further study is needed before tigecycline can be recommended for use in severe C. difficile infection.
OpenAlex reports 31 citations for this work. Citation counts describe recorded attention and do not establish research quality.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Limited data suggest that tigecycline may be of value in the treatment of Clostridiumdifficile infection. We reviewed our experience using tigecycline to treat severe c. difficile and compared outcomes to similarly ill patients who did not receive tigecycline. We found no difference between the groups. Further study is needed before tigecycline can be recommended for use in severe C. difficile infection.
Key concepts: Tigecycline, Clostridium difficile, Medicine, Intensive care medicine, Internal medicine, Antibiotics, Microbiology, Biology